ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024
Mortality and its influencing factors during anti-tuberculosis treatment in pulmonary tuberculosis patients in Hunan Province.
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesReducing mortality during anti-tuberculosis treatment is crucial for completing full-course standardized therapy and achieving tuberculosis cure. The study aims to analyze the mortality and its influencing factors among pulmonary tuberculosis patients undergoing anti-tuberculosis treatment in Hunan Province.
methodsIn this retrospective cohort study, data on pulmonary tuberculosis patients from the Hunan Provincial Tuberculosis Management Information System were collected between January 1, 2019 and December 31, 2023. The cumulative survival rate was estimated using life table methods. Survival rates were compared between groups using the Log-rank test. Cox proportional hazards regression analysis was then employed to explore the influencing factors on mortality during treatment.
resultsThe tuberculosis case fatality rate during anti-tuberculosis treatment in Hunan Province was 0.24%, with the median survival time of tuberculosis-related deaths being 2.41 (2.18-2.63) months. Among the tuberculosis deaths, 47.28% (235/497) occurred during the intensive phase within the first 2 months of treatment. Cox regression analysis showed that older age, male gender, being a farmer, human immunodeficiency virus (HIV) positivity, retreatment status, positive bacteriological test results, medication management by healthcare personnel, and coexisting urinary tract tuberculosis were risk factors for mortality during treatment.
conclusionsThe tuberculosis case fatality rate during anti-tuberculosis treatment among pulmonary tuberculosis patients in Hunan Province is 0.24%. Patients with pulmonary tuberculosis who are older, male, farmers, HIV-positive, undergoing retreatment, have positive bacteriological test results, receive medication management by healthcare workers, or have coexisting urinary tract tuberculosis are at higher risk of death during treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.